Serum TNFi levels in relation to antibodies against adalimumab and infliximab following six months of treatment. by Grith Petersen Eng (3109863)

S1 Table - by Grith Petersen Eng (3109863)

Baseline characteristics of the 26 rheumatoid arthritis patients included in the study. by Grith Petersen Eng (3109863)

Changes in levels of IL-6, sTNF-R1 and sTNF-R2 following 6 months of treatment with adalimumab or infliximab. by Grith Petersen Eng (3109863)

Variables according to development of anti-TNFi Ab production following 6 months of treatment with adalimumab or infliximab. by Grith Petersen Eng (3109863)

Clinical variables and biomarkers according to whether TNFi was detectable in the patients’ blood following 6 months of treatment with adalimumab or infliximab. by Grith Petersen Eng (3109863)

Flow diagram of the selection of patients in this study. by Grith Petersen Eng (3109863)

Prorocentin-5: A Cytotoxic Polyketide from the Benthic Marine Dinoflagellate <i>Prorocentrum lima</i> by Yunseok Choi (5625245)

Patients’ clinicopathological characteristics. by Da young Yu (20536611)

“…In CUSUM analysis, the cases needed to decrease operation time were 10th. The overall complication rate related to implant was 15.09%. …”

Oncologic results. by Da young Yu (20536611)

“…In CUSUM analysis, the cases needed to decrease operation time were 10th. The overall complication rate related to implant was 15.09%. …”

Perioperative parameters. by Da young Yu (20536611)

“…In CUSUM analysis, the cases needed to decrease operation time were 10th. The overall complication rate related to implant was 15.09%. …”

Perioperative complications. by Da young Yu (20536611)

“…In CUSUM analysis, the cases needed to decrease operation time were 10th. The overall complication rate related to implant was 15.09%. …”

Differential distribution of gangliosides GD1b (B), GM1 (C), GD1a (E, the line demarcates the border from which the expression significantly decreases), GT1b (F) and MAG (D) in sag... by Katarina Vajn (464671)

Elementary trends on the time series for the prices of the DJIA during the period from Oct/30/1978 to Jan/09/1979. by Héctor Raúl Olivares-Sánchez (13014866)

Mean and standard deviation of classification accuracy of our multi-view models when trained on 80% high-quality images and tested on 20% high-quality images. by Wanchalerm Pora (8360934)

Demographic and ocular features. by Mingxi Shao (10066570)

“…Adjusting for age and gender, the serum TAS (OR = 0.07, 95% CI 0.01–0.85, <i><i>p</i></i> = 0.037), H₂O₂ (OR = 1.21, 95% CI 1.09–1.35, <i><i>p</i></i> = 0.001) and MDA (OR = 1.17, 95% CI 1.00–1.34, <i><i>p</i></i> = 0.034) were determined to be independent risk/protective factors for PCG. …”

Machine learning model to diagnose PCG. by Mingxi Shao (10066570)

“…Adjusting for age and gender, the serum TAS (OR = 0.07, 95% CI 0.01–0.85, <i><i>p</i></i> = 0.037), H₂O₂ (OR = 1.21, 95% CI 1.09–1.35, <i><i>p</i></i> = 0.001) and MDA (OR = 1.17, 95% CI 1.00–1.34, <i><i>p</i></i> = 0.034) were determined to be independent risk/protective factors for PCG. …”

ROC curves of TAS + SOD + MDA to diagnose PCG. by Mingxi Shao (10066570)

“…Adjusting for age and gender, the serum TAS (OR = 0.07, 95% CI 0.01–0.85, <i><i>p</i></i> = 0.037), H₂O₂ (OR = 1.21, 95% CI 1.09–1.35, <i><i>p</i></i> = 0.001) and MDA (OR = 1.17, 95% CI 1.00–1.34, <i><i>p</i></i> = 0.034) were determined to be independent risk/protective factors for PCG. …”

Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease. by Káryta Suely Macêdo Martins (22404155)

4EBP1 expression in the VAL cells causes asTORi mediated decrease in cap dependent translation and sensitizes them to MLN0128. by Sharmila Mallya (525784)